Press release
B2B Matchmaker for outsourcing in the pharmaceutical industry has started
Freiburg, Germany, November 19, 2009: Pharmatching.com, the first outsourcing portal of its kind for the life sciences and pharmaceutical industry, has been launched. The global B2B portal matches the demand against the supply of all services to be outsourced in the pharmaceutical industry and of active pharmaceutical ingredients. It is particularly advantageous for urgent projects where a service is immediately required or to offer capacities which are currently available.On Pharmatching.com users post self-contained service requests and offers and receive responses directly from those who are interested and a good match. Thereafter the parties directly exchange further details by phone or email.
Pharmatching.com is useful for services in all categories and stages of drug development including contract manufacturing, contract research, laboratory investigations, clinical trial, contractual testing, non-clinical and clinical research, active pharmaceutical ingredients and consulting. The platform thus serves the whole value chain of medicinal products.
Dr. Gabriele Dallmann, founder and CEO of Pharmatching.com comments: “With the growing trend towards outsourcing and virtualization, the identification of suitable service and business partners has become a critical challenge. Pharmatching.com helps to accelerate drug development as it provides companies with an efficient tool to circumvent the time-consuming and expensive searching process”.
Service buyers placing queries for services use the portal for free. Responses to such service requests, the placement of offered services and active pharmaceutical ingredients are subject to a service fee. During the launch phase of Pharmatching.com registration is free and special rates for the service fees are offered.
Pharmatching.com GmbH is located in Freiburg, Germany.
Who we are: Pharmatching.com is a unique globally acting online marketplace specialised in the search for partners for the services-to-outsource in the Life Science industry.
What we do: Pharmatching.com facilitates the search for suitable partners for specific services via its unique Online Matching Platform. It is executed by every user autonomously.
Our users: Small and Medium Enterprises (SME) to Big Pharma, academic and public institutions, freelancers.
Benefit to our users: Our users simply place in their own words “WHAT IS EXACTLY SEARCHED FOR & WHAT IS EXACTLY OFFERED”. The 7 days/24 hours availability of the Online Matching Platform accelerates the searching process for service partners. The platform is of highest quality and saves time and costs significantly compared to common partnering instruments or advertising.
The products where service-to-outsource applies: Human medicinal products, veterinary medicinal products, cosmeceuticals, nutriceuticals, medical devices, diagnostics.
Sectors of the Life science industry served: All sectors of the R&D process and of the value supply chain of medicinal products. This includes all kinds of contract manufacture, laboratory investigations and contractual testing, CROs, i.e. Clinical Research Organisations and Pre-clinical Research Organisations, consulting and legal counselling, logistics and distribution, education, marketing, IT, investment & financing.
Pharmatching.com is a privately-held company located in Freiburg, Germany. The aim of Pharmatching.com is to provide support for the sourcing and outsourcing processes of the Life Science industry and thus facilitate the search for a suitable partner for specific services. It offers its service free of advertisement.
Today the processes around medicinal products and medical devises are increasingly outsourced, academic research has become an essential part of R&D of pharmaceutical companies; and global strategic considerations are commonly applied. Under these circumstances, identification of suitable partners for specific services and their qualification has become a critical challenge for companies. While with the growing trend in outsourcing, the lack of efficient tools to help clients to find appropriate service providers became increasingly apparent Pharmatching.com was developed to meet this need.
The model of Pharmatching.com is based on the longstanding experience of its founder in facilitating drug development as Regulator at the German Health Authority and later as strategic consultant to the Pharmaceutical Industry.
Ease online functions and services meet offline competence by the network of international consultants specialised in qualification and verification of Service Providers in the pharmaceutical industry.
Pharmatching GmbH
Wippertstr. 2
79100 Freiburg
info@pharmatching.com
www.pharmatching.com
Phone: +49 (0)761 13734420
Fax: +49 (0)761 1373444
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release B2B Matchmaker for outsourcing in the pharmaceutical industry has started here
News-ID: 107546 • Views: …
More Releases from Pharmatching GmbH

Pharmatching.com launches "Google for Pharma & Biotech"
Pharmatching.com launches "Google for Pharma & Biotech"
March 20, 2012: The new Pharmatching.com launched its "Google for Pharma & Biotech". The platform is an easy-to-use-“Web2.0”-tool for finding the right partners in the pharmaceutical industry worldwide. It saves time and costs in all (out)sourcing and business development processes, as it fascilitates and accelerates the searching process for appropriate business partners significantly.
The new Pharmatching.com offers a portfolio of more than 5000 service providers…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…